Machine Learning

A new Swiss FinTech, Lubit, launches a prediction market for energy, aiming to replace big-money trading with skill-based crowd intelligence.

With a strategic investment from Coral Tree Partners, Plein Air is set to scale its tech platform and high-touch consultancy for a new era of retail.

Top GMs Fabiano Caruana and Wesley So lead a star-studded field at the 2026 American Cup, battling for $400,000 in a newly expanded Saint Louis venue.

Life sciences consulting firm Trinity lands #7 in Vault's prestigious rankings, signaling a major shift toward technology-enabled commercialization.

A massive $313M federal funding win brings hope to the ALS community, pushing total investment past $1.6B. But how close are we to a real breakthrough?

As Valentine's and Family Day approach, MADD Canada's new campaign confronts a rise in risky behaviour and a decline in public concern over impaired driving.

A new abrasive-free technology from ChEmpower promises to eliminate critical defects, boosting yield and performance for next-generation AI and HBM chips.

The AI-driven lender secured major Wall Street backing for its auto loans, signaling strong investor faith in its tech amid a shaky consumer credit market.

A non-invasive device for spinal cord injury gains major international praise, signaling a shift in neurorehabilitation and a path to market.

A new partnership between Public and Level2 gives retail investors no-code tools to automate trading, but does this empowerment come with hidden risks?

A new health tech firm says its unified platform can fix patient confusion and provider burnout. But in a crowded market, can one company truly solve it all?

Global marketing giant Dentsu partners with BranchLab, using AI to target health audiences with unprecedented precision while upholding patient privacy.

Houston-based S&B expands its Noida office to 500, a strategic move reflecting India's rise as a global engineering hub for the energy sector.

Qodo's new beta integration with Azure DevOps aims to solve the enterprise code quality crisis created by AI-accelerated development.

Australian biotech Amplia Therapeutics is bringing its promising pancreatic cancer trial to the US, a key step in developing a drug that targets the disease's defenses.

As North Carolina's population booms, a new partnership aims to expand access to cutting-edge fertility care, research, and education across the state.

New patents protect Electra's radical blown-lift tech, paving a practical FAA certification path for its EL9 aircraft and challenging the eVTOL model.

Backed by Bessemer & GV, the startup led by Twilio's ex-CEO will commercialize the only fusion approach with proven net energy gain.

Radiation tech giant Mirion appoints three new executives, signaling a major strategic push into next-gen nuclear, advanced cancer care, and AI.

Wesley Pharmaceuticals launches a 503B-compliant NAD+ injection, promising quality in the booming anti-aging market amid scientific debate over its efficacy.